In this issue:
- Economic burden of untreated OSA in the UK/US
- CV/all-cause mortality with positive airway pressure use in OSA
- Oximetry-derived heart rate response as a biomarker for CV risk in OSA
- Arousal threshold and CPAP impact on neurocognitive function in OSA
- Perivascular fluid dynamics and cognition in OSA
- Projected burden of OSA in the US to 2050
- CPAP and cancer risk in OSA
- CPAP vs. mandibular advancement splints in OSA
- Hypoglossal stimulation in OSA
- Recommendations to improve primary care pathways for chronic insomnia
Please login below to download this issue (PDF)